2 months ago
JAZZ
AnalystsJoseph ThomeJoseph Thome's Stock Forecasts
AnalystsJoseph Thome
Sectors:
Analyst Ranking
Top 33%
#1729 out of 5326 analysts
Average Return
+3.83%
Win Rate
62%16 out of 26
Risk vs Reward
Poor
Good
Joseph Thome's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Axsome Therapeutics IncAXSM | +105.48% | $36.49 | $74.98 | 2022-06-29 - 2023-06-28 | Buy |
Intra Cellular Therapies IncITCI | +71.95% | $76.69 | $131.87 | 2024-04-17 - 2025-04-01 | Strong Buy |
Mirum Pharmaceuticals IncMIRM | +60.06% | $74.26 | $118.86 | 2025-09-24 - 2026-07-17 | Strong Buy |
Intra Cellular Therapies IncITCI | +38.77% | $59.89 | $83.11 | 2023-12-11 - 2024-12-10 | Buy |
Jade Biosciences IncJBIO | +37.83% | $483.00 | $665.70 | 2021-07-26 - 2022-07-25 | Buy |
Joseph Thome Analyst Color
Get additional color on Joseph Thome's coverage of popular stocks
Joseph Thome's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alkermes PLCALKS | 2 | Strong Buy | $50.00 | -5.16% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $300.00 | +30.43% | Maintains | a month ago |
Precision Biosciences IncDTIL | 1 | Buy | $20.00 | +154.13% | Initiates Coverage On | a month ago |
Ptc Therapeutics IncPTCT | 4 | Strong Buy | $90.00 | +14.52% | Upgrades | 2 months ago |
Mirum Pharmaceuticals IncMIRM | 4 | Strong Buy | $145.00 | +21.99% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Buy | $275.00 | +11.10% | Maintains | 2 months ago |
United Therapeutics CorpUTHR | 4 | Strong Buy | $660.00 | +23.21% | Maintains | 4 months ago |
Ardelyx IncARDX | 1 | Strong Buy | $10.00 | +92.31% | Maintains | 9 months ago |
Intra Cellular Therapies IncITCI | 2 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Hold | $45.00 | N/A | Downgrades | 3 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Acrivon Therapeutics IncACRV | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Third Harmonic Bio IncTHRD | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Epizyme IncEPZM | 1 | Hold | $1.50 | N/A | Downgrades | 4 years ago |
Intellia Therapeutics IncNTLA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Entrada Therapeutics IncTRDA | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Jade Biosciences IncJBIO | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Allakos IncALLK | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.